Filter
3396
Filtered Results: 3396
Text search:
formulations
Featured
Recommendations
324
New Publications
1033
Language
Document type
No document type
1996
Guidelines
533
Studies & Reports
449
Manuals
138
Strategic & Response Plan
123
Fact sheets
58
Training Material
49
Situation Updates
21
Infographics
17
Resource Platforms
6
Brochures
2
Videos
2
App
1
Online Courses
1
Countries / Regions
India
135
Congo, Democratic Republic of
114
Kenya
101
Global
90
Burkina Faso
83
Senegal
83
Benin
78
Uganda
76
Nepal
69
South Africa
56
Sierra Leone
54
Ethiopia
54
Malawi
54
Rwanda
53
Tanzania
48
Liberia
47
Zambia
46
Myanmar / Burma
46
Cameroon
43
Ghana
41
Nigeria
40
Africa
40
Haiti
39
Bangladesh
36
Madagascar
36
Philippines
34
Central African Republic
33
Latin America and the Carribbean
32
Namibia
30
Guinea
29
Zimbabwe
26
Western and Central Europe
26
Mali
25
Lesotho
22
Cambodia
20
Syria
17
Botswana
17
Niger
16
Indonesia
16
South–East Asia Region
15
West and Central Africa
14
Côte d’Ivoire / Ivory Coast
13
Togo
13
Eswatini/ Swaziland
13
South Sudan
9
Chad
9
Brazil
9
Burundi
9
East and Southern Africa
9
Russia
9
Pakistan
8
Asia
8
Eastern Europe
8
Mozambique
7
Ukraine
7
Lebanon
5
Thailand
5
Middle East and North Africa
5
France
5
Somalia
4
Afghanistan
4
Colombia
4
Sri Lanka
4
Yemen
4
Eastern Europe and Central Asia
4
Venezuela
4
Albania
4
Congo-Brazzaville
4
Tajikistan
4
Georgia
4
Vietnam
4
Morocco
3
Jordan
3
Germany
3
North Macedonia
3
Libya
3
Laos
3
Iran
3
Kyrgyzstan
3
United Kingdom
3
Spain
3
Guinea-Bissau
2
USA
2
Iraq
2
Gambia
2
China
2
Sudan
2
Argentina
2
Peru
2
Serbia
2
Guatemala
2
Chile
2
Western Pacific Region
2
Paraguay
2
Luxembourg
2
Bhutan
2
Djibouti
2
Southern Africa
2
Canada
2
Timor Leste/ East Timor
2
Moldova
2
Kazakhstan
2
Gabon
2
Turkmenistan
2
Belgium
2
Portugal
2
Saudi Arabia
1
Egypt
1
Malaysia
1
Ireland
1
Papua New Guinea
1
Switzerland
1
Hungary
1
Croatia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Greece
1
Angola
1
Nicaragua
1
Other region
1
Poland
1
Palestine
1
Italy
1
Armenia
1
Romania
1
Slovakia
1
Uzbekistan
1
Australia
1
North America
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1506
Clinical Guidelines
353
Women & Child Health
224
Public Health
163
Key Resources
127
Capacity Building
51
Pharmacy & Technologies
32
Toolboxes
COVID-19
239
HIV
212
TB
179
Mental Health
162
AMR
133
Pharmacy
128
Disability
120
Caregiver
102
Ebola
87
Rapid Response
80
Planetary Health
74
NTDs
60
NCDs
43
Global Health Education
36
Refugee
35
Conflict
34
Natural Hazards
34
Cholera
20
Polio
15
Specific Hazards
15
Zika
13
Health Financing Toolbox
12
Social Ethics
11
Typhoon
2
Health Financing
1
Recommendations on the initiation and continuing use of nine common types of contraceptive methods are covered by the tool. In addition to looking at individual medical conditions or characteristics, users may also easily combine multiple conditions or characteristics and view the guidance on each c...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Lignes directrices de l'OMS sur le paludisme
recommended
Les Lignes directrices de l'OMS sur le paludisme rassemblent les recommandations les plus récentes de l'Organisation pour le paludisme dans une plateforme en ligne conviviale et facile à naviguer.
Les Lignes directrices de l'OMS sur le paludisme remplacent 2 publications précédentes de l'OMS: l...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Ce rapport présente une analyse de l'OMS sur les pénuries et le manque de disponibilité des antibiotiques hors brevet en France prenant en compte l'approche Une seule santé. Le rapport est organisé en deux sections : santé animale et santé humaine.
Le rapport vise à donner un éclairage sur...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
L’initiative Médicaments contre les Maladies Négligées (DNDi) est une organisation internationale à but non lucratif spécialisée dans la recherche, le développement et la mise à disposition de traitements sûrs, efficaces et abordables aux patients les plus négligés.
Hand hygiene is vital for safe health care delivery, yet practices at the point of care remain suboptimal worldwide. A comprehensive research agenda is therefore necessary to improve our understanding of factors influencing hand hygiene behaviour and to strengthen appropriate interventions. This age...
